Clinical Trials Directory

Trials / Unknown

UnknownNCT03832335

A New Measurement of Anseikonia Tolerance

Can we Measure Aniseikonia Tolerance in a Normal Population

Status
Unknown
Phase
Study type
Observational
Enrollment
31 (estimated)
Sponsor
Glostrup University Hospital, Copenhagen · Academic / Other
Sex
All
Age
60 Years – 95 Years
Healthy volunteers
Accepted

Summary

Population 1: Measure the effect of size glasses from1-9% on stereopsis Population 2: Measure the effect of size glasses from 1-9% on stereopsis in two settings: * before and after cataract surgery * after dilation of the eye

Detailed description

Population 1: 21 eye healthy phakic individuals. Measurements: baseline stereopsis and stereopsis after size glass (1-9%) is added in front of the right eye and in front og the left eye. This measurement provides details on how much size difference a person can endure without impairing stereopsis. Population 2: 11 phakic eye healthy individuals awaiting cataract operation on both eyes. Measurements are the same as population 1 but this study group is also measured after dilating the eyes. This is to see if accommodation affects the measurement. A postoperative measurement six weeks after cataract operation is also performed to examine if cataract operation affects the measurement.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTMeasurement of aniseikonia toleranceAdding sizeglasses of different percent before right and left eye and measure the impact on stereopsis

Timeline

Start date
2015-07-01
Primary completion
2019-08-02
Completion
2020-12-01
First posted
2019-02-06
Last updated
2019-02-06

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT03832335. Inclusion in this directory is not an endorsement.

A New Measurement of Anseikonia Tolerance (NCT03832335) · Clinical Trials Directory